The Medlab Middle East 2024 was held in Dubai World Trade Center from February 5th to 8th 2024. Medlab brings together over 900 exhibitors from 40 countries to showcase the latest innovations and technologies in the field of medical laboratory. From global manufacturers to established laboratory suppliers, all major industry players are gearing up to interact, network, and conduct business over four fantastic days.
Standing at the forefront of technological advancements, Hipro, an IVD company with a rich international presence since 2006, showcased China's prowess in science and technology. The spotlight was on our DX-1 microfluidics immunoassay system and PalmF, drawing admiration from professional visitors for their groundbreaking features.
.jpg "PHOTO_20240207_092701997(1).jpg")
Debuting at Medlab, the DX-1 microfluidics immunoassay system introduced the revolutionary 'reagent jet' liquid phase microfluidic platform, capturing the attention of industry enthusiasts. This unique feature became a focal point, emphasizing Hipro's commitment to pushing the boundaries of innovation.
.jpg "PHOTO_20240207_092702447(1).jpg")
Beyond the immediate success at the exhibition, the DX-1 and PalmF's presence heralds a promising future. Their advanced functionalities and applicability position Hipro at the forefront of the market, signifying broad prospects in the evolving landscape of medical laboratory technologies. As we continue to break new ground, Hipro remains dedicated to shaping the future of microfluidics and handheld instrumentation in the global healthcare arena.
